Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]

Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma

Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan...

Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma ( Prof Heinrich Lokhorst - Universitair Medisch Centrum Utrecht, Heidelberglaan, Netherlands )

Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic...

Dr Valentin Goede - University Hospital of Cologne, Germany

Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic leukaemia ( Dr Valentin Goede - University Hospital of Cologne, Germany )

Role of microenvironment and stroma in cancer therapy

Dr Stephen Ansell - Mayo Clinic, Rochester, USA

Role of microenvironment and stroma in cancer therapy ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )

Adding bevacizumab to standard first-line chemoradiation for glioblastoma gives...

Prof Mark Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA

Adding bevacizumab to standard first-line chemoradiation for glioblastoma gives no survival benefit ( Prof Mark Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA )

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )

Crizotinib superior to chemo for advanced ALK positive NSCLC

Dr Suresh S. Ramalingam - Emory University, Atlanta, USA

Crizotinib superior to chemo for advanced ALK positive NSCLC ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )

Axillary radiotherapy provides alternative to invasive early stage breast...

Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam

Axillary radiotherapy provides alternative to invasive early stage breast cancer surgery ( Dr Emiel J. Rutgers - Netherlands Cancer Institute, Amsterdam )

Paclitaxel dosing equally effective in preventing breast cancer progression

Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA

Paclitaxel dosing equally effective in preventing breast cancer progression ( Dr Andrew Seidman - Memorial Sloan-Kettering Cancer Center, New York, USA )

Paclitaxel chemotherapy schedules equally effective for early-stage breast...

Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA

Paclitaxel chemotherapy schedules equally effective for early-stage breast cancer ( Dr G. Thomas Budd - Cleveland Clinic, Cleveland, USA )

Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer

Dr Suresh S. Ramalingam - Emory University, Atlanta, USA

Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )

Paclitaxel chemotherapy schedules are equally effective for early-stage breast...

Dr G. Thomas Budd - MD Cleveland Clinic, USA

Paclitaxel chemotherapy schedules are equally effective for early-stage breast cancer ( Dr G. Thomas Budd - MD Cleveland Clinic, USA )

Extended use of tamoxifen reduces breast cancer recurrence and death

Prof Richard Gray - University of Oxford, Oxford, United Kingdom

Extended use of tamoxifen reduces breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, United Kingdom )

More from ecancer